- call +1-201-465-4211
- email sales@mrinsights.biz
Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.
Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.
This report studies the eosinophilic esophagitis drug market.
Scope of the Report:
The classification of eosinophilic esophagitis drug includes budesonide, fluticasone and other types, and the proportion of budesonide in 2017 is about 52%.
North America is the largest consumption region of eosinophilic esophagitis drug, with a sales market share nearly 32% in 2017. Europe is the second largest consumption region of eosinophilic esophagitis drug, enjoying Sales market share nearly 29% in 2017.
Market competition is intense. AstraZeneca, GSK, Bayer are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Eosinophilic Esophagitis Drug is expected to grow at a CAGR of roughly 6.2% over the next five years, will reach 150 million US$ in 2024, from 100 million US$ in 2019, according to a new study.
This report focuses on the Eosinophilic Esophagitis Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
AstraZeneca
GSK
Bayer
Adare Pharmaceuticals
DBV Technologies
Dr. Falk Pharma
Quorum Innovations
Shire
Calypso
Celgene
Regeneron
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Budesonide
Fluticasone
Others
Market Segment by Applications, can be divided into
Hospitals
Clinics
Drugstore
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Eosinophilic Esophagitis Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Eosinophilic Esophagitis Drug, with price, sales, revenue and global market share of Eosinophilic Esophagitis Drug in 2017 and 2018.
Chapter 3, the Eosinophilic Esophagitis Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Eosinophilic Esophagitis Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Eosinophilic Esophagitis Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Eosinophilic Esophagitis Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Eosinophilic Esophagitis Drug Introduction
1.2 Market Analysis by Type
1.2.1 Budesonide
1.2.2 Fluticasone
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Drugstore
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Eosinophilic Esophagitis Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Eosinophilic Esophagitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 GSK
2.2.1 Business Overview
2.2.2 Eosinophilic Esophagitis Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GSK Eosinophilic Esophagitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Bayer
2.3.1 Business Overview
2.3.2 Eosinophilic Esophagitis Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer Eosinophilic Esophagitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Adare Pharmaceuticals
2.4.1 Business Overview
2.4.2 Eosinophilic Esophagitis Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 DBV Technologies
2.5.1 Business Overview
2.5.2 Eosinophilic Esophagitis Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 DBV Technologies Eosinophilic Esophagitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Dr. Falk Pharma
2.6.1 Business Overview
2.6.2 Eosinophilic Esophagitis Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Quorum Innovations
2.7.1 Business Overview
2.7.2 Eosinophilic Esophagitis Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Quorum Innovations Eosinophilic Esophagitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Shire
2.8.1 Business Overview
2.8.2 Eosinophilic Esophagitis Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Shire Eosinophilic Esophagitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Calypso
2.9.1 Business Overview
2.9.2 Eosinophilic Esophagitis Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Calypso Eosinophilic Esophagitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Celgene
2.10.1 Business Overview
2.10.2 Eosinophilic Esophagitis Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Celgene Eosinophilic Esophagitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Regeneron
2.11.1 Business Overview
2.11.2 Eosinophilic Esophagitis Drug Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Regeneron Eosinophilic Esophagitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Eosinophilic Esophagitis Drug Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Eosinophilic Esophagitis Drug Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Eosinophilic Esophagitis Drug Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Eosinophilic Esophagitis Drug Manufacturer Market Share in 2018
3.3.2 Top 6 Eosinophilic Esophagitis Drug Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Eosinophilic Esophagitis Drug Market Analysis by Regions
4.1 Global Eosinophilic Esophagitis Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Eosinophilic Esophagitis Drug Sales and Market Share by Regions (2014-2019)
4.1.2 Global Eosinophilic Esophagitis Drug Revenue and Market Share by Regions (2014-2019)
4.2 North America Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
4.3 Europe Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
4.5 South America Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
5 North America Eosinophilic Esophagitis Drug by Country
5.1 North America Eosinophilic Esophagitis Drug Sales, Revenue and Market Share by Country
5.1.1 North America Eosinophilic Esophagitis Drug Sales and Market Share by Country (2014-2019)
5.1.2 North America Eosinophilic Esophagitis Drug Revenue and Market Share by Country (2014-2019)
5.2 United States Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
5.3 Canada Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
5.4 Mexico Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
6 Europe Eosinophilic Esophagitis Drug by Country
6.1 Europe Eosinophilic Esophagitis Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Eosinophilic Esophagitis Drug Sales and Market Share by Country (2014-2019)
6.1.2 Europe Eosinophilic Esophagitis Drug Revenue and Market Share by Country (2014-2019)
6.2 Germany Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
6.3 UK Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
6.4 France Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
6.5 Russia Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
6.6 Italy Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
7 Asia-Pacific Eosinophilic Esophagitis Drug by Country
7.1 Asia-Pacific Eosinophilic Esophagitis Drug Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Eosinophilic Esophagitis Drug Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Eosinophilic Esophagitis Drug Revenue and Market Share by Country (2014-2019)
7.2 China Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
7.3 Japan Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
7.4 Korea Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
7.5 India Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
8 South America Eosinophilic Esophagitis Drug by Country
8.1 South America Eosinophilic Esophagitis Drug Sales, Revenue and Market Share by Country
8.1.1 South America Eosinophilic Esophagitis Drug Sales and Market Share by Country (2014-2019)
8.1.2 South America Eosinophilic Esophagitis Drug Revenue and Market Share by Country (2014-2019)
8.2 Brazil Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
8.3 Argentina Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
8.4 Colombia Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
9 Middle East and Africa Eosinophilic Esophagitis Drug by Countries
9.1 Middle East and Africa Eosinophilic Esophagitis Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Eosinophilic Esophagitis Drug Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Eosinophilic Esophagitis Drug Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
9.3 Turkey Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
9.4 Egypt Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
9.5 Nigeria Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
9.6 South Africa Eosinophilic Esophagitis Drug Sales and Growth Rate (2014-2019)
10 Global Eosinophilic Esophagitis Drug Market Segment by Type
10.1 Global Eosinophilic Esophagitis Drug Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Eosinophilic Esophagitis Drug Sales and Market Share by Type (2014-2019)
10.1.2 Global Eosinophilic Esophagitis Drug Revenue and Market Share by Type (2014-2019)
10.2 Budesonide Sales Growth and Price
10.2.1 Global Budesonide Sales Growth (2014-2019)
10.2.2 Global Budesonide Price (2014-2019)
10.3 Fluticasone Sales Growth and Price
10.3.1 Global Fluticasone Sales Growth (2014-2019)
10.3.2 Global Fluticasone Price (2014-2019)
10.4 Others Sales Growth and Price
10.4.1 Global Others Sales Growth (2014-2019)
10.4.2 Global Others Price (2014-2019)
11 Global Eosinophilic Esophagitis Drug Market Segment by Application
11.1 Global Eosinophilic Esophagitis Drug Sales Market Share by Application (2014-2019)
11.2 Hospitals Sales Growth (2014-2019)
11.3 Clinics Sales Growth (2014-2019)
11.4 Drugstore Sales Growth (2014-2019)
12 Eosinophilic Esophagitis Drug Market Forecast (2019-2024)
12.1 Global Eosinophilic Esophagitis Drug Sales, Revenue and Growth Rate (2019-2024)
12.2 Eosinophilic Esophagitis Drug Market Forecast by Regions (2019-2024)
12.2.1 North America Eosinophilic Esophagitis Drug Market Forecast (2019-2024)
12.2.2 Europe Eosinophilic Esophagitis Drug Market Forecast (2019-2024)
12.2.3 Asia-Pacific Eosinophilic Esophagitis Drug Market Forecast (2019-2024)
12.2.4 South America Eosinophilic Esophagitis Drug Market Forecast (2019-2024)
12.2.5 Middle East and Africa Eosinophilic Esophagitis Drug Market Forecast (2019-2024)
12.3 Eosinophilic Esophagitis Drug Market Forecast by Type (2019-2024)
12.3.1 Global Eosinophilic Esophagitis Drug Sales Forecast by Type (2019-2024)
12.3.2 Global Eosinophilic Esophagitis Drug Market Share Forecast by Type (2019-2024)
12.4 Eosinophilic Esophagitis Drug Market Forecast by Application (2019-2024)
12.4.1 Global Eosinophilic Esophagitis Drug Sales Forecast by Application (2019-2024)
12.4.2 Global Eosinophilic Esophagitis Drug Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Eosinophilic Esophagitis Drug Picture
Table Product Specifications of Eosinophilic Esophagitis Drug
Figure Global Sales Market Share of Eosinophilic Esophagitis Drug
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
